SEC Form D private-offering filing

Mercury Bio, Inc.

Name: Mercury Bio, Inc. - new SEC Form D private-offering filing, Santa Fe, NM
Published: 2025-10-24

A new SEC Form D private-offering notice from Santa Fe, NM, a $7,954,094 filer-stated offering target in Biotech. The source filing is one click away.

Mercury Bio, Inc. site↗ Verified via SEC Form D

Biotechnology company developing an intracellular drug delivery platform using engineered extracellular vesicles to treat neurodegenerative diseases such as Alzheimer's and Parkinson's.

Filed 2025-10-24Filed to raise $7,954,094First money in 2025-09-30Raised so far $2,376,107HQ (as filed) Santa Fe, NMSector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified mercurybio.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in New Mexico →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.